Cheryl Chan

Davis Polk advised the dealer manager in connection with a “modified Dutch auction” cash tender offer by MicroStrategy Incorporated for 432,313 of its shares of common stock at a purchase…

Davis Polk is advising Gilead Sciences, Inc. in its acquisition of Immunomedics, Inc. for $88.00 per share in cash. The transaction, which values Immunomedics at approximately $21 billion,…

We are advising L Brands on the separation of Victoria’s Secret

Davis Polk is advising Brookfield Business Partners L.P. on its $13.2 billion acquisition of the Power Solutions business of Johnson Controls International plc. The transaction is expected…

Davis Polk is advising SUEZ S.A. on its $601 million sale of 20% of SUEZ Water Resources Inc. to PGGM. The transaction is expected to be completed by the first half of 2019, subject to…

Davis Polk is advising Williams on its $10.5 billion acquisition of all of the outstanding public common units of Williams Partners L.P. in an all stock-for-unit transaction at a 1.494…

Davis Polk is advising SS&C Technologies Holdings, Inc. on its approximately $5.4 billion acquisition of DST Systems, Inc. The transaction, which is expected to close by the third…

Davis Polk is advising CSX Corporation in connection with an agreement with Mantle Ridge LP to reconstitute CSX’s board of directors. Under the terms of the agreement, CSX has appointed…

Davis Polk is advising Roche Holding Ltd. in connection with the sale of an active pharmaceutical ingredients manufacturing facility in Florence, South Carolina, to Patheon N.V. Under the…

Davis Polk is advising Atairos Group, Inc. on its acquisition of Learfield Communications, Inc. from Providence Equity Partners and other shareholders. Financial terms of the transaction…